Live Chat

Giao dịch Vir Biotechnology VIR

Bán
 Mua

VirBiotechnology biểu đồ trực tiếp

5m 15m 30m 1h 4h 1d 1w

Kiến thức cơ bản về công cụ

Weekly Search
Weekly
Daily
Ngày Đóng Thay đổi % Thay đổi Mở Cao Thấp

Tin tức mới nhất

A graph showing us stock futures mildly decline after S&P 500 record close.
Vanessa L 2025 Jan 24, 06:30

US Stock Futures Decline After S&P 500 Record Close

Shares Stocks US500
Frances Wang 2025 Jan 23, 16:00

Tesla stock prediction 2025: forecast for the tesla share price

TSLA Stocks Shares
Frances Wang 2025 Jan 23, 16:00

Zuckerberg sold stock: He Sells $2 Billion in Meta Stock Amid AI Push

Stocks
Frances Wang 2025 Jan 23, 16:00

Financial compensation news: Car compensation may affect working people

CFD Trading
Hand holding mobile with Tesla logo and upward stock arrow, reflecting Tesla Model Y price increase.
Vanessa L 2025 Jan 23, 11:00

Tesla Model Y Price Hike Sparks Debate Across Canada

TSLA Stocks Shares
Gold bullion and U.S. dollar bills, reflecting trends in gold coin prices.
Vanessa L 2025 Jan 23, 10:20

Gold Coin Prices Steady Amid Dollar Weakness

Gold USD Commodities Fed
Apple stock news with Chinese flag on smartphone, highlighting market challenges.
Vanessa L 2025 Jan 23, 08:30

Apple Stock News Amid Revenue Diversification

Stocks Shares AAPL China
BOJ rate hike
Tommy Yap 2025 Jan 22, 17:00

Morning Note: BOJ’s Rate Hike: How Will It Shape Markets?

BoJ Forex

Thông tin

Chênh lệch

0.11

Tỷ lệ Spread (%)

0.9883 %

Đòn bẩy

1:5

Lãi suất Qua đêm Mua

-0.0597 %

Lãi suất Qua đêm Bán

-0.0292 %

Forex

USD

Giờ giao dịch

Thị trường đã đóng cửa.

Thứ sáu

14:31 - 20:59

Thứ hai

14:31-20:59

Thứ ba

14:31-20:59

Thứ tư

14:31-20:59

Thứ năm

14:31-20:59

Phân tích và thống kê

Mở

---

Đóng trước đó

---

52 Tuần Cao/Thấp

--- – ---

Giá trị vốn hóa thị trường

1450191616

Cổ phiếu nổi bật

137720000

Ngày báo cáo thu nhập (tiếp theo)

0000-00-00

Tỷ suất cổ tức

Ngày giao dịch không hưởng quyền

Tỷ lệ cổ tức thường niên kỳ hạn

0

Tỷ suất cổ tức thường niên kỳ hạn

0

EPS

-3.93

Tìm hiểu thêm về công cụ này

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.

Các công cụ liên quan

Tài sản
Bán
Mua
% Thay đổi

Giao dịch ngay

Giao dịch ngay

Giao dịch ngay

Giao dịch ngay
Các công cụ liên quan
Trustpilot
Live Chat